Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05388812 · ClinicalTrials.gov registry record · NA
Together in Recovery With Veterans Through Employment
A NA study of Veterans With Opioid Use Disorder, sponsored by VA Office of Research and Development.
- Active
- Registry status
- NA
- Development phase
- 123
- Enrollment target
- 2
- Study locations
NCT05388812: Active NA study of Veterans With Opioid Use Disorder, sponsored by VA Office of Research and Development.
NCT05388812 is a NA study of Veterans With Opioid Use Disorder that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 123 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05388812, a NA study of Veterans With Opioid Use Disorder, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 123 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to help Veterans who have opioid use problems with gaining and maintaining meaningful employment. The investigators also want to know employment helps with other aspects of the Veteran's life including starting and staying on necessary medications, mental health needs, and feeling a part of society.
Primary Outcome
A "week worked" is defined as working either part time or full time in a competitive job during a Sunday to Saturday 7-day window. Competitive employment is defined as a job that pays at least minimum wage or is based on salary or commission, is based in a setting alongside others without disabilities, and is not reserved for people with disabilities
Conditions Studied
Interventions
- OTHER Treatment As Usual Vocational Rehabilitation (TAU-VR)
- OTHER Individual Placement and Support (IPS)
Study Locations (2)
Alabama
- Birmingham VA Medical Center, Birmingham, AL - Birmingham
- Tuscaloosa VA Medical Center, Tuscaloosa, AL - Tuscaloosa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 123 participants |
| Start Date | 2022-12-16 |
| Est. Completion | 2027-09-30 |
| Phase | NA |
What the registry record for NCT05388812 still lists
NCT05388812 is an interventional study that assigns participants to a tested intervention. The registered 123 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Veterans With Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment As Usual Vocational Rehabilitation (TAU-VR) is the first listed.
NCT05388812 reports a single indexed study location in Alabama.
Frequently Asked Questions
What is clinical trial NCT05388812 about?
NCT05388812 is a clinical study titled "Together in Recovery With Veterans Through Employment". The purpose of this study is to help Veterans who have opioid use problems with gaining and maintaining meaningful employment. The investigators also want to know employment helps with other aspects of the Veteran's life including starting and staying on necessary medications, mental health needs, a...
What is the current status of trial NCT05388812?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 123 participants. The study started on 2022-12-16. Estimated completion is 2027-09-30.
What conditions does trial NCT05388812 study?
This clinical trial studies the following conditions: Veterans With Opioid Use Disorder.
What interventions are being tested in trial NCT05388812?
The interventions under investigation include: Treatment As Usual Vocational Rehabilitation (TAU-VR) (OTHER), Individual Placement and Support (IPS) (OTHER).
Who is sponsoring clinical trial NCT05388812?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05388812 being conducted?
This trial has 2 study locations across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05388812's enrollment target sits among peer trials
123 762nd of 2000 higher than 1,239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05285891 · 123 participants · Phase 4
Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis
- NCT05334368 · 123 participants · Phase 3
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
- NCT06088355 · 123 participants · NA
Moderate Versus High Volume Light-Moderate Intensity Exercise for People With Moderate Parkinson's Disease
- NCT06111131 · 123 participants · NA
Ancora-SB Overtube Complete Positioning and Optical Visualization During Endoscopic Procedures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI